SCHEMBL22649442

SCHEMBL22649442

CC(C)C(NC(=O)CCc1ccccc1)C(=O)OC(C)(C)C

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KLK5 Q9Y337 1/20 0.54
▸ CCR1 P32246 2/20 0.47
▸ SMN1; SMN2 Q16637 1/20 0.46
▸ ACE P12821 1/20 0.46
▸ HDAC2 Q92769 1/20 0.45
▸ HDAC8 Q9BY41 1/20 0.45
▸ HDAC6 Q9UBN7 1/20 0.45
▸ RAB9A P51151 1/20 0.45
▸ PRSS1 P07477 1/20 0.44
▸ CTSG P08311 1/20 0.44
▸ CTRB1 P17538 1/20 0.44
▸ CMA1 P23946 1/20 0.44
▸ HRH3 Q9Y5N1 1/20 0.44
▸ CPB2 Q96IY4 1/20 0.44
▸ ALDH1A1 P00352 2/20 0.44
▸ L3MBTL1 Q9Y468 1/20 0.44
▸ SDCBP O00560 1/20 0.43
▸ SDC2 P34741 1/20 0.43
▸ POLB P06746 1/20 0.43
▸ GAA P10253 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7276321 0.84 ERAP2 (0.58) CCR1SMN1; SMN2HDAC2HDAC8HDAC6
SCHEMBL7276329 0.84 ERAP2 (0.58) CCR1SMN1; SMN2HDAC2HDAC8HDAC6
SCHEMBL6446379 0.82 ALDH1A1 (0.56) CCR1SMN1; SMN2HDAC2HDAC8HDAC6
SCHEMBL5711363 0.82 ALDH1A1 (0.56) CCR1SMN1; SMN2HDAC2HDAC8HDAC6
SCHEMBL30887591 0.82 ACE (0.60) KLK5ACECTSGCMA1ALDH1A1
SCHEMBL30291800 0.82 ACE (0.60) KLK5ACECTSGCMA1ALDH1A1
SCHEMBL2063189 0.81 CASP1 (0.50) KLK5ACEHDAC2HDAC8HDAC6
SCHEMBL27706581 0.81 CASP1 (0.50) KLK5ACEHDAC2HDAC8HDAC6
SCHEMBL20885259 0.80 SYK (0.59) KLK5
SCHEMBL11657615 0.80 SYK (0.59) KLK5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200354318-A1 THIOSEMICARBAZATES AND USES THEREOF THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH (US) 2020-11-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200354318-A1 THIOSEMICARBAZATES AND USES THEREOF TST, ABAT, AADAC KLK5 2003/4885CCR1 4049/4885SMN1; SMN2 3731/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback